1. Academic Validation
  2. Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1

Ferroptosis inhibitor alleviates Radiation-induced lung fibrosis (RILF) via down-regulation of TGF-β1

  • J Inflamm (Lond). 2019 May 29;16:11. doi: 10.1186/s12950-019-0216-0.
Xuan Li 1 2 Lijie Duan 3 Sujuan Yuan 2 Xibing Zhuang 2 Tiankui Qiao 2 Jian He 1
Affiliations

Affiliations

  • 1 1Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032 China.
  • 2 2Department of Radiation Oncology, Jinshan Hospital, Fudan University, 1508 Longhang Road, Shanghai, 201508 China.
  • 3 3Department of Neurology, Jinshan Hospital, Fudan University, 1508 Longhang Road, Shanghai, 201508 China.
Abstract

Background: Radiation-induced lung fibrosis (RILF) is a severe and life-threatening complication of thoracic radiotherapy. Cell death is the key issue in RILF. Ferroptosis is a form programmed cell death implicated in the pathologies of inflammation. This study aimed to investigate the role of Ferroptosis in RILF, and the effectiveness and the potential underlying mechanism of Ferroptosis inhibitor on RILF.

Methods: Immunofluorescence, western blot and RT-PCR assays were performed to examine the Ferroptosis maker Glutathione Peroxidase 4 (GPX4) in a mice RILF model. The lung tissue sections were stained with hematoxylin and eosin (H&E), Masson trichrome staining and Sirius-Red staining to evaluate the histopathological changes in RILF mice. Reactive Oxygen Species (ROS) and hydroxyproline (HYP) in lungs were measured by the relevant kits. The serum levels of inflammatory cytokines (TNF-α, IL-6, IL-10, and TGF-β1) were measured with Elisa. The protein and mRNA levels of GPX4, nuclear factor (erythroid-derived 2)-like 2 (Nrf2), hemeoxygenase-1 (HO1) and quinone oxidoreductase 1 (NQO1) in lungs were examined by western blot and RT-PCR.

Results: GPX4 levels of the irradiated lungs were significantly down-regulated than the groups with no irradiation, and the Ferroptosis inhibitor, liproxstatin-1, increased GPX4 levels significantly in RILF mice. Treatment with liproxstatin-1 lowered the Szapiel and Ashcroft scores significantly, down-regulated the levels of ROS and HYP in lungs and reduced the serum inflammatory cytokines levels in RILF mice. The protein and the mRNA levels of Nrf2, HO1 and NQO1 were up-regulated by liproxsratin-1 in RILF.

Conclusions: Our data suggested that Ferroptosis played a critical role in RILF, Ferroptosis inhibitor liproxstatin-1 alleviated RILF via down-regulation of TGF-β1 by the activation of Nrf2 pathway. The effectiveness of Ferroptosis inhibition on RILF provides a novel therapeutic target for RILF.

Keywords

Ferroptosis; Ferroptosis inhibitor; Nrf2; ROS; Radiation-induced lung fibrosis; TGF-β1.

Figures
Products